The R&D Fund supports small and medium enterprises (SMEs) and scaleups to commercialise products that address the health, social or economic impacts of the COVID-19 pandemic.
The R&D investment fund is a $6 million single-round competitive scheme administered by Investment NSW for SMEs. Available funding is in the range of $250,000 to $1 million, depending on the product's stage of development and is targeted at products within a technology readiness level (TRL) 4-9 that address the health, social or economic impacts of COVID-19.
Funding can be used for purposes including:
- conducting market and product assessments
- salaries and access to external expertise that is directly related to delivery of the project
- commercialisation strategies and commercial feasibility studies
- specialist equipment or infrastructure necessary to progress the project.
To learn more and for full eligibility criteria, visit R&D Fund.